Doherty Institute @thedohertyinst.bsky.social · 29/04/2026Today is Day of Immunology, recognising immunologists and their impact on modern medicine. By deepening our understanding of how the immune system responds to disease, immunology helps inform advances such as vaccine development. 023
Doherty Institute @thedohertyinst.bsky.social · 25/03/2026Interested in helping research looking at immune responses to vaccines against mosquito-borne diseases? If you’re 18 - 60 years with no serious immune problems, you may be eligible for our study in Melbourne. 🔗 For more info visit bit.ly/47JVRIl 021
Doherty Institute @thedohertyinst.bsky.social · 23/03/2026Your generation can fight Chlamydia. Ready to help? Chlamydia is one of the most common STIs worldwide. In more than 80% of cases, individuals have no symptoms and are unaware they are infected. If you are aged 18-29 years, you may be eligible to join this vaccine trial. 🔗 bit.ly/4ajaZ1Z 021
Doherty Institute @thedohertyinst.bsky.social · 19/03/2026Your generation can fight Chlamydia. Ready to help? Chlamydia is one of the most common STIs worldwide. In more than 80% of cases, individuals have no symptoms and are unaware they are infected. If you are aged 18-29 years, you may be eligible to join this vaccine trial. 🔗 bit.ly/4ajaZ1Z 000
Doherty Institute @thedohertyinst.bsky.social · 16/03/2026🔬 50 years of electron microscopy (EM) at VIDRL, from Australia’s first HIV ultrastructural images in the 1980s to the first local images of SARS‑CoV‑2. EM is a vital tool for detecting and characterising pathogens during outbreaks. Find out more 🔗 bit.ly/4sLZOoK 173
Doherty Institute @thedohertyinst.bsky.social · 15/03/2026Interested in helping research looking at immune responses to vaccines against mosquito-borne diseases? If you’re 18 - 60 years with no serious immune problems, you may be eligible for our study in Melbourne. 🔗 For more info visit bit.ly/47JVRIl 022
Doherty Institute @thedohertyinst.bsky.social · 10/03/2026Your generation can fight Chlamydia. Ready to help? Chlamydia is one of the most common STIs worldwide. In more than 80% of cases, individuals have no symptoms and are unaware they are infected. If you are aged 18-29 years, you may be eligible to join this vaccine trial. 🔗 bit.ly/4ajaZ1Z 011
Doherty Institute @thedohertyinst.bsky.social · 07/03/2026Interested in helping research looking at immune responses to vaccines against mosquito-borne diseases? If you’re 18 - 60 years with no serious immune problems, you may be eligible for our study in Melbourne. 🔗 For more info visit bit.ly/47JVRIl 000
Doherty Institute @thedohertyinst.bsky.social · 27/02/2026Your generation can fight Chlamydia. Ready to help? Chlamydia is one of the most common STIs worldwide. In more than 80% of cases, individuals have no symptoms and are unaware they are infected. If you are aged 18-29 years, you may be eligible to join this vaccine trial. 🔗 bit.ly/4ajaZ1Z 000
Doherty Institute @thedohertyinst.bsky.social · 25/02/2026Interested in helping research looking at immune responses to vaccines against mosquito-borne diseases? If you’re 18 - 60 years with no serious immune problems, you may be eligible for our study in Melbourne. 🔗 For more info visit bit.ly/47JVRIl 011
Doherty Institute @thedohertyinst.bsky.social · 17/02/2026Your generation can fight Chlamydia. Ready to help? Chlamydia is one of the most common STIs worldwide. In more than 80% of cases, individuals have no symptoms and are unaware they are infected. If you are aged 18-29 years, you may be eligible to join this vaccine trial. 🔗 bit.ly/4ajaZ1Z 010
Doherty Institute @thedohertyinst.bsky.social · 16/02/2026Interested in helping research looking at immune responses to vaccines against mosquito-borne diseases? If you’re 18 years or older with no serious immune problems, you may be eligible for our study in Melbourne. 🔗 For more info visit bit.ly/47JVRIl 023
Doherty Institute @thedohertyinst.bsky.social · 07/01/2026Doherty Institute secures $12.9M NHMRC Ideas Grants for 9 projects tackling antimicrobial resistance, TB, HIV, cancer immunology & immune biology—advancing new ways to fight infections & immune-related diseases. 🔗 bit.ly/4aJ6gas 062
Doherty Institute @thedohertyinst.bsky.social · 17/12/2025A new approach using possum poo surveillance and cutting-edge genomics can provide an early-warning system to flag emerging Buruli ulcer hot spots before human cases occur. www.doherty.edu.au/news-events/news… 000
Doherty Institute @thedohertyinst.bsky.social · 17/12/2025🎥 New video series: Questions from the Community Hosted by our Community Advisory Board, these Q&As connect researchers with the public. First up: COVID-19 insights with A/Prof Katherine Gibney—testing, antivirals, vaccines & more. Watch here 🔗 bit.ly/49eRd7c 011
Doherty Institute @thedohertyinst.bsky.social · 10/12/2025We're excited to announce the first artworks created through the Lionel Gell Art in Science Initiative have been unveiled at the Doherty Institute in partnership with @vca_mcm. www.doherty.edu.au/news-events/news… 020
Doherty Institute @thedohertyinst.bsky.social · 30/11/2025Interested in helping research looking at immune responses to vaccines against mosquito-borne diseases? If you’re 18 years or older with no serious immune problems, you may be eligible for our study in Melbourne. 🔗 For more info visit bit.ly/47JVRIl 012
Doherty Institute @thedohertyinst.bsky.social · 24/11/2025Interested in helping research looking at immune responses to vaccines against mosquito-borne diseases? If you’re 18 years or older with no serious immune problems, you may be eligible for our study in Melbourne. 🔗 For more info visit bit.ly/47JVRIl 000
Doherty Institute @thedohertyinst.bsky.social · 20/11/2025Interested in helping research looking at immune responses to vaccines against mosquito-borne diseases? If you’re 18 years or older with no serious immune problems, you may be eligible for our study in Melbourne. 🔗 For more info visit bit.ly/47JVRIl 000
Doherty Institute @thedohertyinst.bsky.social · 18/11/2025Five Doherty Institute researchers have made Clarivate's Highly Cited Researchers 2025 list, demonstrating significant and broad influence in their fields of research. Find out more 🔗 www.doherty.edu.au/news-events/news… 000
Doherty Institute @thedohertyinst.bsky.social · 17/11/2025Congratulations to our researchers who have been awarded over $11 million through the 2026 Australian Research Council (ARC) Discovery Project grants, recognising their leadership in advancing knowledge of the immune system, infection and human health. Find out more 🔗 bit.ly/43Dpjyx 212
Doherty Institute @thedohertyinst.bsky.social · 15/11/2025Interested in helping research looking at immune responses to vaccines against mosquito-borne diseases? If you’re 18 years or older with no serious immune problems, you may be eligible for our study in Melbourne. 🔗 For more info visit bit.ly/47JVRIl 000
Doherty Institute @thedohertyinst.bsky.social · 10/11/2025Interested in helping research looking at immune responses to vaccines against mosquito-borne diseases? If you’re 18 years or older with no serious immune problems, you may be eligible for our study in Melbourne. 🔗 For more info visit bit.ly/47JVRIl 002
Doherty Institute @thedohertyinst.bsky.social · 24/09/2025Behind the scenes of the Australian Institute for Infectious Disease build. An exciting milestone to see demolition close to completion, paving the way for construction on the state-of-the-art research facility. Learn more 🔗 bit.ly/4no192U @burnetinstitute.bsky.social @unimelb.bsky.social 040
Doherty Institute @thedohertyinst.bsky.social · 18/03/2025In a recent study published in Science Advances, the University of Melbourne's @carissaaurelia.bsky.social, PhD Candidate in the Chung Lab highlights the importance of COVID-19 boosters, especially for those with a weaker immune system. go.unimelb.edu.au/5rxp 010
Doherty Institute @thedohertyinst.bsky.social · 17/03/2025Laureate Professor @pcdoherty.bsky.social speaks about the state of public discourse, attitudes towards public health today, how we best prepare for the next pandemic and the still great potential in medical research. Read the full story, originally published by 360info go.unimelb.edu.au/ez6p 032